Source: CNS & Neurological Disorders - Drug Targets. Unidade: FMRP
Subjects: CANABINOIDES, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, FÁRMACOS
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis. CNS & Neurological Disorders - Drug Targets, v. 14, n. 8, p. 970-978, 2015Tradução . . Disponível em: https://doi.org/10.2174/1871527314666150909113930. Acesso em: 04 dez. 2025.APA
Crippa, J. A. de S., Hallak, J. E. C., Abilio, V. C., Lacerda, A. L. T., & Zuardi, A. W. (2015). Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis. CNS & Neurological Disorders - Drug Targets, 14( 8), 970-978. doi:10.2174/1871527314666150909113930NLM
Crippa JA de S, Hallak JEC, Abilio VC, Lacerda ALT, Zuardi AW. Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis [Internet]. CNS & Neurological Disorders - Drug Targets. 2015 ; 14( 8): 970-978.[citado 2025 dez. 04 ] Available from: https://doi.org/10.2174/1871527314666150909113930Vancouver
Crippa JA de S, Hallak JEC, Abilio VC, Lacerda ALT, Zuardi AW. Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis [Internet]. CNS & Neurological Disorders - Drug Targets. 2015 ; 14( 8): 970-978.[citado 2025 dez. 04 ] Available from: https://doi.org/10.2174/1871527314666150909113930